Seya T, Kurita M, Iwata K, Yanagi Y, Tanaka K, Shida K, Hatanaka M, Matsumoto M, Jun S, Hirano A, Ueda S, Nagasawa S
Department of Immunology, Center for Adult Diseases Osaka, Japan.
Biochem J. 1997 Feb 15;322 ( Pt 1)(Pt 1):135-44. doi: 10.1042/bj3220135.
Two phosphatidylinositol (PI)-anchored versions of a measles virus (MV) receptor membrane cofactor protein (MCP; CD46) were generated by fusing the extracellular domain of MCP to the decay-accelerating factor (DAF; CD55) or its PI anchor. The PI-anchored forms of MCP expressed on Chinese hamster ovary cells, otherwise non-permissive to MV, conferred a smaller MV cytopathic effect than a wild-type MCP, a Ser/Thr-rich domain-deletion mutant and a cytoplasmic tail-deletion mutant of MCP. Therefore the differences in MV receptor properties between the two PI-anchored and three transmembrane forms were investigated. The PI-anchored forms were predominantly expressed on microvilli as in DAF, whereas the other transmembrane forms were found on intracellular membranes. The PI-anchored forms conferred high MV-binding capacity compared with the transmembrane versions. MV replication was, however, severely suppressed in cells expressing the PI-anchored forms, resulting in ineffective syncytium formation. In contrast, cell-to-cell fusion occurred efficiently after co-transfection of cDNA species encoding MV-H. MV-F and any version of MCP. Thus the PI-anchored forms, despite showing sufficient MV binding and cell-to-cell fusion competence together with MV-H and MV-F, mediate inefficient MV entry or replication, which causes severe suppression of the MV cytopathic effect. A biased receptor distribution on microvilli might participate in the selection of a low MV uptake pathway in the PI-anchored forms of MCP. Taken together, the transmembrane portion of MCP is a critical factor for effective virus-cell fusion and the subsequent MV replication.
通过将麻疹病毒(MV)受体膜辅因子蛋白(MCP;CD46)的胞外结构域与衰变加速因子(DAF;CD55)或其磷脂酰肌醇(PI)锚定区融合,构建了两种PI锚定形式的MCP。在中国仓鼠卵巢细胞(该细胞原本对MV不敏感)上表达的PI锚定形式的MCP,与野生型MCP、富含丝氨酸/苏氨酸结构域缺失突变体和MCP胞质尾缺失突变体相比,其介导的MV细胞病变效应较小。因此,研究了两种PI锚定形式和三种跨膜形式的MV受体特性差异。PI锚定形式主要如DAF一样表达于微绒毛上,而其他跨膜形式则存在于细胞内膜上。与跨膜形式相比,PI锚定形式具有较高的MV结合能力。然而,在表达PI锚定形式的细胞中,MV复制受到严重抑制,导致无效的合胞体形成。相反,在共转染编码MV-H、MV-F和任何形式MCP的cDNA后,细胞间融合高效发生。因此,PI锚定形式尽管与MV-H和MV-F一起显示出足够的MV结合和细胞间融合能力,但介导的MV进入或复制效率低下,这导致MV细胞病变效应受到严重抑制。微绒毛上偏向性的受体分布可能参与了PI锚定形式的MCP中低MV摄取途径的选择。综上所述,MCP的跨膜部分是有效病毒-细胞融合及随后MV复制的关键因素。